Mass Spectrometry is key technology for studying critical molecules and pathways. Defining molecular targets is crucial for the process of drug development.
In our group, we are focused on using proteomics, mass spectrometry and biochemical approaches to understand disease processes.
Proteomics and Mass Spectrometry
The group has expertise in proteomics based methodologies and hosts a platform containing a variety of chromatography equipment and mass spectrometers.
Our team
-
Benedikt Kessler
Professor of Biochemistry and Mass Spectrometry
-
Georgina Berridge
Research Assistant
-
Philip Charles
Bioinformatician/Statistician
-
Andreas Damianou
Postdoctoral Researcher
-
Sarah Flannery
Research Assistant in Proteomics
-
Svenja Hester
Research Assistant
-
Hannah Jones
Postdoctoral Researcher
-
Darragh O'Brien
Head of Structural & Mechanistic Proteomics
-
Iolanda Vendrell
Technologly Lead, Discovery Proteomics SRF
-
Zhanru Yu
Research Assistant
-
Bohan Yu
Visiting Student
- For Non-Scientists
- Research Overview
- Mass Spectrometry
-
Publications
- Publications 2025
- Publications 2023
- Publications 2024
- Publications 2022
- Publications 2021
- Publications 2020
- Publications 2019
- Publications 2018
- Publications 2017
- Publications 2016
- Publications 2015
- Publications 2014
- Publications 2013
- Publications 2012
- Publications 2011
- Publications 2010
- Publications 2009
- Publications 2005-2008
- Publications 2001-2004
- Publications 1997-2000
- Public Engagement
- Photo Gallery
- Virtual tour of the Kessler Lab
- Contact
- News
- Collaborators
- Former Group Members
Recent publications
Towards light-coupled sample preparation for time-resolved cryoEM studies
Journal article
Hadjidemetriou K. et al, (2026), IUCrJ, 13, 395 - 408
Circulating tumor necrosis factor α in deceased donors promotes kidney injury and associates with inferior short- and long-term graft function and survival
Journal article
Fawaz S. et al, (2026), American Journal of Transplantation, 26, 1390 - 1403
USP24 is a cross-reactive DUB targeting MOV10 to regulate IFN-I production.
Journal article
Mukhopadhyay R. et al, (2026), Nature communications
Multidimensional proteomics and explainable AI feature selection identify cross-platform lung cancer molecular signature in blood plasma.
Journal article
Gushterov N. et al, (2026), Communications medicine
Urine Recirculation During Normothermic Kidney Preservation Improves Energy Balance Involving the Urea and Citric Acid Cycles
Journal article
Weissenbacher A. et al, (2026), Transplantation Direct, 12, e1947 - e1947
